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We report the selective modification of engineered cysteine 
residues in peptides derived from a Cys2His2 zinc finger 
motif. The chemoselective modification is achieved thanks to 
the protecting effect exerted by the zinc cation upon 
coordination with the native cysteines and histidines of the 10 
zinc-finger fold, and allows the straightforward 
bioconjugation to DNA binding zinc finger constructs. 
The covalent modification of proteins is a powerful strategy to 
modulate their macromolecular function.1 Nature accomplishes 
such alterations through a variety of post-translational 15 
modifications that modify the activity of the modified proteins.2 
Inspired by nature, scientists have long pursued the development 
of methodologies that could emulate these natural post-
conjugation reactions and allow the introduction of desired 
groups or labels in specific sites of proteins.1,3 For a reaction to 20 
be of general use, it should selectively target the residue of 
interest in the presence of competing side chains of the 
unprotected polypeptide, and in aqueous environments.  
 Many of the strategies so far developed for the site-selective 
modification of proteins rely on the introduction of designed 25 
amino acids equipped with orthogonally reactive groups that can 
be coupled to external reactants, for instance, by using the well 
known click chemistry.4 Although this strategy allows high levels 
of selectivity, it requires the introduction of non-natural amino 
acids.5 Alternatively, one could pursue the modification of 30 
specific natural amino acids in proteins, but achieving a good 
combination of reactivity and chemoselectivity is extremely 
challenging. In this context, most of the successful modifications 
of unprotected peptides or proteins have relied on the 
nucleophilic reactivity window provided by the sulfur atom in 35 
cysteine side chains,6 which allowed a number of selective 
alkylations with a variety of electrophiles. A major problem of 
this strategy arises when the peptide or protein of interest have 
more than one cysteine residue, because of the competitive 
formation of polyalkylated products.7 40 
 We report the selective modification of cysteine residues 
incorporated into a zinc finger peptide that features two 
additional cysteines as part of a classical Cys2His2 motif. In 
presence of Zn(II) these cysteines are trapped in the ββα 
secondary fold and thereby exhibit a much-decreased reactivity 45 
(Fig. 1). The ligation allows a straightforward approach to 
bisbenzamidine-zinc finger conjugates capable of binding to 
designed DNA target sequences. Since the zinc finger is a natural 
motive present in many transcription factors, this work opens a 
door for the chemoselective access to zinc finger derivatives, and 50 
for the modification and/or tagging of zinc finger proteins. 
 
Figure 1. Schematic illustration of the approach for the chemoselective 
synthesis of zinc finger derivatives. a) unfolded peptide with three 
nucleophilic sites; b) zinc-promoted folding and cysteine coordination 55 
leaves only a single nucleophilic site for modification. 
 The zinc finger family is the largest among eukaryotic 
transcription factors, and responsible of regulating the expression 
of a myriad of genes controlling fundamental cellular programs.8 
The DNA recognition by zinc finger proteins has served as 60 
inspiration for the engineering of a large variety of highly 
appealing artificial gene regulators.9 Despite the relevance of zinc 
finger proteins, work towards their selective chemical 
modification has been very scarce. There are a number of reports 
on the reactivity of zinc thiolates of different zinc fingers that 65 
suggest that, while the cysteines in charged Zn(Cys)4 and 
Zn(Cys)3His motifs react with electrophiles or oxidants, neutral 
Zn(Cys)2(His)2 are less reactive.10 Therefore, we reasoned that 
zinc finger structures might provide a natural protection for the 
two cysteines involved in the coordination to the metal ion, and 70 
thereby favor the selective modification of other cysteines present 
in the peptide, providing a rapid and versatile way of making zinc 
finger derivatives. 
 To test the approach we synthesized model peptides 1 and 2, 
which exhibit the sequence of two different types of Cys2His2 75 
fragments, together with an additional cysteine engineered either 
at the N-terminus (1) or in the side chain of an internal lysine (2). 
The zinc finger sequence of peptide 1 is based on a fragment of 
the C-terminal Cys2His2 unit of the trimeric Zif268 transcription 
factor (residues Pro162 to Arg187 in the crystal structure).11 Peptide 80 
2 contains the Cys2His2 unit of the DNA-binding domain of the 
GAGA transcription factor of Drosophila melanogaster (from 
residues Ser28 to Phe58 in the reference structure).12 Peptide 2 
includes a mutation of Arg44 to Lys to allow the selective 
introduction of a cysteine group in its side chain.13 Both peptides 85 
were assembled using standard Fmoc protocols and HBTU as 
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coupling agent. The Lys residue of peptide 2 was introduced as 
alloc derivative for its selective manipulation in the solid phase 
(see the ESI). 
   
Figure 2. Structure of model peptides derived from Zif268 (1) and 5 
GAGA (2). Arrows point to the thiols to be selectively modified.  
 We tested the selectivity in the alkylation of the sulfur side 
chains in the peptides with benzyl bromoacetate, a very good 
electrophile that is commercially available. The reactions were 
carried out in parallel, in the absence and in the presence of 1.5 10 
equiv of ZnSO4, and in a desoxygenated phosphate buffer (pH 
7.5) under argon atmosphere. The reactions were monitored by 
RP-HPLC and the identity of the products was confirmed by 
mass spectrometry. For peptide 1 the alkylation was carried out at 
rt in presence of 4 equiv of benzyl bromoacetate. After 10 min, 15 
LC-MS analysis of an aliquot of the reaction carried out in the 
absence of Zn (II) showed a mixture of several products, the 
major being the trialkylated adduct (retention time 22.36 min). 
The HPLC peak at 19.45 min corresponds to a monoalkylated 
derivative (Fig. 3 left, and ESI). Interestingly, when the reaction 20 
was carried out in presence of ZnSO4 we observed a different 
outcome, with the exclusive formation of a monoalkylated 
derivative (retention time 18.42 min). The other peaks correspond 
to the starting peptide 1 (16.73 min) and benzyl bromoacetate 
(Fig. 3, right).  25 
 
Figure 3. HPLC traces of the reactions of peptide 1 (200 µM) with benzyl 
bromoacetate (4 equiv), in the absence (left) and in the presence (right) of 
1.5 equiv of ZnSO4, after 10 minutes of reaction at rt, in a desoxygenated 
phosphate buffer (pH 7.5). Peaks with asterisk: benzyl bromoacetate.  30 
 For the full identification of the monoalkylated product of the 
Zn containing reaction we did a MS/MS study of the fragments 
obtained after digestion of the modified peptide with trypsin. 
After 2h of digestion, HPLC of the mixture showed two peaks 
with double-charged signals at 851.36347 and 787.31604 (see 35 
ESI), which correspond to fragments cleaved at Lys171 (y14 
fragment) and Arg170. The deconvoluted MS/MS spectra of the 
first peak shows signals corresponding to the y ion series of the 
partial sequence GC159AGPFAC165DIC168GRK, where Cys159 is 
the cysteine alkylated with benzyl bromoacetate, and Cys165 and 40 
Cys168 are carbamidomethyl cysteines,14 which are formed during 
the treatment of the sample before digestion (see the ESI). The 
mass difference of 251.04275 between the signals at 1602.68829 
(y13) and 1351.62554 (y12) can only be accounted for if the 
cysteine alkylated with benzyl bromoacetate is next to the 45 
acetylated glycine. Interestingly, the monoalkylated derivatives 
obtained in presence or in absence of Zn (II) are different, which 
suggests that the intrinsic reactivity of the terminal cysteine is 
lower than that of the internal ones. 
 50 
Figure 4. Left: schematic representation of the fragmentations of the y 
ion. Right: structure of the monoalkylated peptide 3. 
 Peptide 2 is analog to one previously used by us to construct 
DNA binding peptide conjugates containing a zinc finger 
fragment and a minor groove binder,13 and seemed particulary 55 
appropriate to apply the chemoselective strategy for the 
preparation of DNA binders. Previous synthesis of this—and 
related—conjugates required the solid phase modification of the 
peptide chain with the minor groove binder, which represented an 
important drawback in terms of efficiency and versatility.15 60 
Therefore we first analyzed the reactivity of peptide 2 with 
benzyl bromoacetate, and found that, after only 5 min at 5 ºC in 
absence of Zn(II) it was fully converted into the trialkylated 
adduct (25.09 min, Fig. 5, left). However, in the presence of 
ZnSO4 the reaction resulted mainly in the formation of a 65 
monoalkylated product (22.17 min, for details see the ESI).  
 
Figure 5. HPLC chromatograms, after 5 minutes at 5 ºC, of the reactions 
of peptide 2 (200 µM) with benzyl bromoacetate (4 equiv), in the absence 
(left) and in the presence (right) of 1.5 equiv of ZnSO4 and in a 70 
desoxygenated phosphate buffer (pH 7.5).  
 The reaction outcome is consistent with the folding of the 
peptide precursor 2 in the presence of Zn(II), as shown by the 
increase in the negative ellipticity at 208/222 nm meausred by 
circular dichroism (see ESI).16 Moreover, the spectral changes 75 
displayed by the monoalkylated product in the presence of zinc 
are similar to those observed for the precursor peptide, and are 
therefore consistent with the exclusive modification of the 
cysteine in the side chain of Lys44, since alkylation of either of 
these cysteines would prevent such conformational changes.  80 
 More importantly, when the reaction was carried out with a 
more challenging electrophile equipped with a bisbenzamidine 
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presence of 1.5 equiv of ZnSO4. Moreover, the resulting 
conjugate is an efficient and selective DNA binder, as 
demonstrated by EMSA (Figure 6).18 Therefore, the 
chemoselective ligation provides a very simple approach to 
functional zinc finger peptides, and opens the possibility of 5 
running related reactions with recombinant zinc fingers.     
 
 
Figure 6. Top: Synthesis of conjugate 4. Bottom: EMSA results; Lanes 1-
10: [4] = 0, 100, 200, 300, 400, 500, 600, 800, 900, 1000 nM with 50 nM 10 
of AT•GAGA dsDNA (SYBR gold staining).  Oligonucleotide sequence 
(binding site underlined, only one strand shown): AT•GAGA: 5'-
GACGGAATTTGAGAGCGTCG -3'. 
Conclusions 
The Zn(II) cation can be exploited both as a folding agent and as 15 
a protecting group. This double role allows the selective 
modification of cysteines present in zinc finger peptides that are 
not involved in the formation of the Cys2His2-Zn fold. The 
strategy provides a direct approach to functional DNA binding 
zinc finger conjugates, and promises to be useful for the post-20 
transcriptional modification of zinc finger proteins. 
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